Recent news on Plavix

Sanofi's Plavix wins EU backing for stent patients  -  25 May 2007
ReutersLONDON, May 25 (Reuters) - Sanofi-Aventis SA's Plavix (SASY.PA: Quote, Profile, Research has been recommended by European regulators for use in preventing

EU drug panel doesn't back Amgen's Vectibix for colon cancer  -  25 May 2007
MarketWatchPlavix is currently authorised for prevention of atherothrombotic events in patients suffering from myocardial infarction, ischaemic stroke or established

Feds Investigate Profits From Off-Label Heart Stent Procedures ...  -  May 21, 2007
Lawyers and Settlements,With the drug costing about $4 per day, the increased use of DES had already provided a goldmine for Plavix marketers Bristol-Myers Squibb and

Doubling Plavix Dose Recommended Before Angioplasty  -  May 14, 2007
MedIndia,A new study reveals doubling the current recommended dose of Plavix to angioplasty patients, from 300 milligrams to 600, cut the combined risk of heart

Bristol admits lies in Plavix probe  -  May 12, 2007
NorthJersey.com,Bristol-Myers also said Thursday that the proposed guilty plea in the Plavix case wouldn't affect the upcoming June 15 expiration of a "deferred-prosecution

Bristol to plead guilty in Plavix case  -  May 11, 2007
CNNMoney.comThe charges relate to representations made by a former Bristol senior executive during the renegotiation of the proposed Plavix settlement in May 2006 that

Bristol to plead guilty to charges in Plavix deal  -  May 10, 2007
Canada.com,At issue is a patent settlement involving Bristol, marketing partner Sanofi-Aventis , and the Canadian generic drug maker Apotex over Plavix.

Bristol-Myers agrees to plead guilty to false statements ...  -  May 10, 2007
International Herald Tribune,Apotex had wanted to sell a generic version of Plavix before the US patent expired in 2011. Bristol-Myers and its Plavix co-marketer, Sanofi-Aventis,

Bristol to admit guilt in Plavix patent case  -  May 11, 2007
Los Angeles Times,The companies agreed last year to keep generic Plavix off the market until just months before the patent expired. The deal was rejected by state attorneys

Bristol-Myers Squibb To Plead Guilty In Two Plavix Settlement ...  -  May 10, 2007
Trading Markets,Plavix, a blood thinner manufactured by Paris-based Sanofi-Aventis SA (SNY | charts | news | PowerRating) and marketed by New York-based Bristol-Myers

Bristol-Myers to plead guilty on Plavix  -  May 11, 2007
Euro2day,Co has said it will plead guilty to two antitrust charges carrying a total maximum fine of 1 mln usd over last year''s failed Plavix patent settlement.

Total links Sanofi stake sale to Plavix ruling  -  May 9, 2007
ReutersN: Quote, Profile, Research, are in a patent battle over Plavix with generic drugmaker Apotex Inc. A US court is due to rule on the case later this year.

Lab testing confirms counterfeit drug in Malta  -  May 20, 2007
MaltaMedia,The drug certified as counterfeit is Plavix 75mg and was imported in Malta as part of a large consignment on 7 December 2006. The medicine was not intended

Bristol Counts on Plavix Resurgence  -  Apr 25, 2007
TheStreet.comThe injunction remains in effect while a judge decides whether Apotex infringed on the Plavix patent held by Sanofi-Aventis (SNY - Cramer's Take

Bristol-Myers Squibb relieved to see Plavix back on track  -  Apr 27, 2007
Pharma Times (subscription),An upturn in sales of its antithrombotic blockbuster Plavix has lead to Bristol-Myers Squibb posting better-than-expected results for the first quarter.

Unilab set to contest patent of 4 drug items  -  May 20, 2007
Manila Standard Today,Plavix is retailed by Bristol-Myers Squibb. Ochave said bringing down the cost of medicines, especially essential drugs, was Unilab’s primary reason why it

Unilab set to contest patent of 4 drug items  -  May 20, 2007
Therapeutics Daily (subscription) (press release),Seretide, a drug administered to patients with asthma and chronic obstructive pulmonary disease; Unasyn, an anti-bacterial medicine; and Plavix,

The State Dominates Best-Selling Drug List  -  May 21, 2007
NJBIZ,Blood thinner Plavix, the only drug in the ranking with negative year-over-year growth, briefly faced generic competition in 2006 until a federal judge

Research and Markets: Gain an Insight into the Financial ...  -  May 18, 2007
PharmaLive.com (press release),In the midst of a long-term strategic reinvention of itself, can BMS carry on if the generic challenge to its leading product Plavix is successful?

Higher Dose of Clot-Buster Is Better Before Artery Procedure  -  May 11, 2007
CBC News,FRIDAY, May 11 (HealthDay News) - Cardiologists should be giving more of the clot-preventing drug Plavix than is now recommended before performing the

Weights unapt to free clots  -  May 21, 2007
Denver Post,The Plavix and aspirin you are taking help prevent blood clots from forming in your coronary arteries and within your stents. If you developed a blood clot

Research and Markets: Examine the M&A Activity of the Generics ...  -  May 18, 2007
Genetic Engineering News (press release),In 2006, Apotex received eleven ANDA approvals, including one for clopidogrel bisulphate, the generic form of sanofi-aventis' Plavix.

Research and Markets: Examine the M&A Activity of the Generics ...  -  May 18, 2007
Business Wire (press release),In 2006, Apotex received eleven ANDA approvals, including one for clopidogrel bisulphate, the generic form of sanofi-aventis’ Plavix.

Bare-metal Stents Are Better for Some Heart Patients  -  May 16, 2007
DG NewsA four-week course of the blood thinner clopidogrel (Plavix) after an interventional heart procedure. • Deferral of the second, non-cardiac surgery for five

Doctors profiting from prescriptions is wrong  -  May 20, 2007
Concord Monitor,Another company, Bristol-Meyers Squibb, pleaded guilty to lying about its blood-clotting drug, Plavix. Even more troubling was a Times report that two giant

Bristol: To merge, or not to merge?  -  26 Apr 2007
CNNMoney.comWith earnings due, watch Plavix sales and for any comments on a new CEO; merger plans with Sanofi? By Aaron Smith, CNNMoney.com staff writer

Generics cited as Bristol-Myers' net slips  -  26 Apr 2007
Therapeutics Daily (subscription) (press release),...last summer of generic competition for its best-selling Plavix drug as well as the loss of patent protection for cholesterol agent Pravachol.

Rally Set for a Sequel  -  26 Apr 2007
Smartmoney.comSales of the company's blood thinner Plavix came in higher than expected, and Bristol lifted its full-year guidance by 12 cents a share.

Bristol Counts on Plavix Resurgence  -  Apr 25, 2007
TheStreet.comThe injunction remains in effect while a judge decides whether Apotex infringed on the Plavix patent held by Sanofi-Aventis (SNY - Cramer's Take

Update: US envoy urges drug talks  -  Apr 23, 2007
Bangkok Post,And some 200000 patients in Thailand who suffer from heart conditions have blood clotting problems that could be treated with Plavix, but only 20 per cent

Drug makers Bristol-Myers, Sanofi-Aventis face FTC probe over ...  -  Apr 3, 2007
Canada.com,The disclosure of the FTC probe Tuesday is the latest fallout from Bristol-Myers' and Sanofi-Aventis' botched Plavix settlement negotiations with Apotex

Bristol, Sanofi face FTC probe over Plavix deal  -  Apr 3, 2007
MarketWatch...related to last year's proposed settlement of patent litigation with a generic-drug company surrounding the heart drug Plavix.

US envoy urges Thailand to talk with drug firms  -  Apr 23, 2007
Bangkok Post,And some 200000 patients in Thailand who suffer from heart conditions have blood clotting problems that could be treated with Plavix, but only 20 per cent

Bristol-Myers, Sanofi Subpoenaed in Plavix Drug Probe (Update3)  -  Apr 3, 2007
BloombergIn February, a federal prosecutor in New Jersey said Bristol-Myers didn't violate securities laws in trying to delay generic Plavix.

US Inquiry Into Bid to Suppress a Generic Plavix  -  Apr 3, 2007
New York Times,In February, a federal prosecutor in New Jersey said that Bristol-Myers had not violated securities laws in trying to delay generic Plavix.

Bristol-Myers gets FTC request on Plavix  -  Apr 3, 2007
Crain's New York Business,Bristol-Myers Squibb Co. on Tuesday said in a regulatory filing that it received a subpoena from the Federal Trade Commission over its failed Plavix patent

FTC demands documents from B-MS and Sanofi in Plavix probe  -  Apr 4, 2007
Pharma Times (subscription),The firms are now waiting to see how the judge in the New York trial will rule on Apotex's request to declare the Plavix patent invalid and unenforceable

Bristol-Myers Gets US Subpoena in Plavix Probe (Update1)  -  Apr 3, 2007
Bloomberg...from US antitrust regulators seeking documents related to a settlement the company made with Apotex Inc. to delay competition for the heart pill Plavix.

Bristol Myers seen reporting lower earnings  -  Apr 19, 2007
MarketWatchIn particular, investors and analysts will be focused on sales of Plavix, which is used to help ward of blood clots. Plavix is co-marketed with

Over-The-Counter Aspirin is Best Choice for Most Consumers Needing ...  -  Apr 12, 2007
PR Newswire (press release),Clopidogrel (Plavix) plus aspirin is superior treatment for selected patients WASHINGTON, April 12 /PRNewswire-USNewswire/ -- For most people who need a

Over-The-Counter Aspirin is Best Choice for Most Consumers Needing ...  -  Apr 12, 2007
Earthtimes.orgAlmost all adults with risk factors-alone are candidates for aspirin and do not need one of the other, more expensive antiplatelet medicines such as Plavix.

Drug firm should give self a shot in the arm  -  Apr 19, 2007
The Courier News,The outcome of this patent infringement trial is important to BMY because Plavix (a clot-busting blockbuster drug and the second-largest prescribed drug in

Police close to "solve" Malta-link on counterfeit drugs  -  Apr 14, 2007
maltaStar.com,The drug, Plavix 75mg coated tablets, arrived in Malta on the 7 December 2006 and was stored at the Customs Warehouse of the Malta Freeport.

Medical Devices - April 2007 Litigation Update Part II  -  Apr 9, 2007
Lawyers and Settlements,Due to the increased risk of blood clots, DES patients are now being told that they have to take the blood-thinning drug Plavix together with aspirin every

Drugmakers to take earnings medicine  -  Apr 16, 2007
CNNMoney.comBristol-Myers' blockbuster Plavix was still getting squeezed in the first quarter by privately held competitor Apotex, which flooded the market in 2006 with

Over-The-Counter Aspirin is Best Choice for Most Consumers Needing ...  -  Apr 19, 2007
Therapeutics Daily (subscription) (press release),The other three are Aggrenox (a combination of aspirin and the drug dipyridamole), clopidogrel (Plavix), and ticlopidine (Ticlid).

Small strokes warn of big trouble  -  Apr 18, 2007
DetNews.com,Aspirin, aspirin plus extended-release dipyridamole or Plavix are such medicines. Or it might be going on the anticoagulant Coumadin. See another doctor.

Bristol Says FTC Has Requested  -  Apr 3, 2007
Wall Street Journal (subscription),That probe also is related to the proposed settlement over Plavix, the world's second best-selling drug, behind Pfizer Inc.'s Lipitor.

Anticlotting drugs: Aspirin is still the best choice for most  -  Apr 11, 2007
Consumer ReportsFor people who need more protection than aspirin alone can provide, prescription clopidogrel (Plavix), either alone or combined with aspirin,

Sanofi Gets Daiichi Panaldine Japan Rights  -  Apr 2, 2007
Reuters.uk,The transfer of the rights of Panaldine, a predecessor to Sanofi's blockbuster drug Plavix and known elsewhere as Ticlid, was expected to be concluded by

Bristol-Myers Squibb asked by FTC to produce documents related to ...  -  Apr 3, 2007
San Diego Union Tribune,In the settlement, Bristol-Myers and Plavix partner Sanofi-Aventis SA intended to pay the Canadian drug maker Apotex to keep a lower-cost generic version of

Heart of a survivor  -  Apr 25, 2007
Yahoo! SportsOn that day, doctors allowed him to stop taking Plavix, a blood thinner. Because he was off blood thinners, Brocail could again start using the

Cardiovascular drugs take Sanofi's business to over 115m euros  -  Apr 16, 2007
Ziarul Financiar,The drug Plavix, which is used for cardiovascular treatment, is the market leader for antithrombotic (anti-clogging) drugs.

Drug firms cooperate in FTC probe  -  Apr 4, 2007
Los Angeles Times,Bristol-Myers and Sanofi-Aventis say they will supply documents related to their failed bid to delay generic competition to Plavix.

Bristol-Myers Gets FTC Document Request  -  Apr 3, 2007
Forbes,In the settlement, Bristol-Myers and Plavix partner Sanofi-Aventis (nyse: SNY - news - people ) SA intended to pay the Canadian drug maker Apotex to keep a

Clearing the heart confusion  -  Apr 3, 2007
Health24.com,For that reason, patients are advised to take blood-thinners such as aspirin and clopidogrel (Plavix) for at least one year after stent placement.

Stent maker commits $40m to post-op kits  -  Apr 1, 2007
Boston Globe,Right now, most patients are told to take Plavix for three to six months, depending on the stent they've got, and to remain on aspirin indefinitely to

Sanofi denies rift at the top over direction of the group  -  Mar 28, 2007
Pharma Times (subscription),The newspaper says that a bid for B-MS is unlikely before outstanding litigation over Plavix has been settled. The case revolves around a patent deal struck

Sanofi reportedly split on Bristol deal  -  Mar 27, 2007
Newark Star Ledger,That triggered a 62 percent slide in sales of branded Plavix, which had 2005 sales of $5.9 billion. Bristol-Myers CEO Peter Dolan resigned in September over

Market Report -- Short Stories (BMY)  -  Apr 13, 2007
MSN MoneyBut the Plavix circumstance unfortunately underscores for investors precisely what awaits in 2011/2012, if not sooner. Briefing.com is the leading Internet

Bristol-Myers Says FTC Seeks Files on Apotex Deal  -  Apr 3, 2007
Reuters.uk,Apotex then flooded the United States with its cheaper form of Plavix, causing sales of Bristol's branded product to plunge.

Stocks gain after falling crude oil rekindles optimism  -  Apr 4, 2007
Mountain Mail Newspaper,The request is related to documentation from last year, when the companies unsuccessfully bid to delay a generic version of the blood thinner Plavix from

Bristol-Myers Squibb Gets Civil Investigative Demand From FTC  -  Apr 3, 2007
PharmaLive.com (press release),...with a Civil Investigative Demand regarding the Plavix settlement with Apotex, Inc. An excerpt from the filing is below and the full filing is attached.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional